Study to Assess the Effect Of Alosetron On Mucosal Blood Flow

Irritable Colon Clinical Trial

Official title:
A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects

Status Completed

Clinical Trial Summary

This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00370032
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 4
Start date	December 2006
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01855711` - Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)	Phase 2
Terminated	`NCT00423345` - Colon Investigation - Factors Determining Choice of Procedure
Completed	`NCT00101985` - Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)	Phase 2
Completed	`NCT00376896` - Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers	Phase 1
Completed	`NCT00067457` - Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy	Phase 3
Completed	`NCT00067561` - Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy	Phase 3
Terminated	`NCT00461682` - Sb-705498 Rectal Pain Study	Phase 2
Completed	`NCT00385099` - Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome	Phase 2